Oklahoma reaches $8.75 million settlement with opiate maker

OKLAHOMA CITY (AP) — The state of Oklahoma will receive $8.75 million from two pharmaceutical companies in a deal that will end legal action that the state was considering against the opioid manufacturers.

Oklahoma Attorney General Mike Hunter announced the agreement on Friday with Endo Pharmaceuticals Inc. and Par Pharmaceutical, Inc., both subsidiaries of Dublin-based Endo International. Without the agreement, Hunter said he planned to file suit against the company, alleging it violated state law by deceptively marketing opioid pain medications in a way that understated the risk of addiction.

The company denied the allegations and admits no wrongdoing as part of the agreement.